DNA RNA and Cells

19 Oct 2009 StemCells, Inc.'s Neural Stem Cells Show Promise for Treating Age-Related Macular Degeneration
16 Oct 2009 Oxford BioMedica Announces Update on ProSavinĀ® Phase I/II Trial in Parkinsons Disease And Publication of Preclinical Results
14 Oct 2009 California Stem Cell, Inc. and Families of Spinal Muscular Atrophy Announce Completion of Pre-IND Meeting with FDA for Stem Cell-Derived Therapy for the Treatment of Spinal Muscular Atrophy Type I
14 Oct 2009 GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
12 Oct 2009 MDRNA Reports UsiRNA Reduces Tumor Growth In Vivo
08 Oct 2009 RXi Pharmaceuticals Presented New Pre-Clinical Animal Data at its Annual Investor Day
07 Oct 2009 Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-2125, a TLR9 Agonist, in Combination with Ribavirin for Chronic Hepatitis C Virus Infection
07 Oct 2009 Living Cell Technologies Reports Successful First Implant Of DIABECELLĀ® In New Zealand
28 Sep 2009 Vical Licensee Sanofi-aventis Completes Enrollment in Phase 3 Angiogenesis Trial
23 Sep 2009 Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
23 Sep 2009 Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
22 Sep 2009 Advanced Cell Completing Pre-Clinical Activities in Preparation for IND Filing
21 Sep 2009 Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
18 Sep 2009 MOLOGEN reaches further objective in clinical study
15 Sep 2009 Alnylam and Medtronic Present New Late-Stage Pre-clinical Data on ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease
14 Sep 2009 ALTAIR THERAPEUTICS REPORTS SUCCESSFUL PHASE I STUDY OF INHALED AIR645
14 Sep 2009 Scientific Journal Gene Therapy Reports That Cardium's Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
14 Sep 2009 ZaBeCor Pharmaceuticals Begins Phase II Clinical Trial in Asthma Patients Following Positive Phase I Results
10 Sep 2009 StemCells, Inc. To Initiate First Ever Neural Stem Cell Trial In Myelination Disorder
10 Sep 2009 MESOBLAST'S PROPRIETARY STEM CELLS SUCCESSFULLY REPAIR/REGENERATE DAMAGED INTERVERTEBRAL DISC CARTILAGE
10 Sep 2009 Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral
09 Sep 2009 REGADO BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN RADAR (Phase 2b) STUDY OF REG1 ANTICOAGULATION SYSTEM
08 Sep 2009 LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
08 Sep 2009 Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
03 Sep 2009 NOXXON Is Awarded Research and Development Grant for First-in-Human Clinical Trial with SpiegelmerĀ® NOX-A12

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top